SRT Therapeutics
San Diego, US · Founded 2024 · Delaware corporation
Founders & leadership
LO
Lauren OtsukiinExecutive
Board
RB
Rolf BenirschkeBoard director
BG
Brian G. Feagan, M.D.Board director
EP
Ed PrunchunasBoard director
MW
Michael WalshBoard director
SW
Shierley WidjajaBoard director
Reported raises · per SEC filings
Form D private placements$47.4M disclosed across 1 round · 2025
▶$47.4MraisedAug 2025 · 55 investors · BiotechnologyRule 506(b)
▶$47.4MraisedAug 2025 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rolf BenirschkeDirector
- Brian G. Feagan, M.D.Director
- Ed PrunchunasDirector
- Michael WalshDirector
- Lauren OtsukiExecutive Officer, Director
- Shierley WidjajaDirector
- Offering amount
- $47.5M
- Amount sold
- $47.4M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has SRT Therapeutics raised?
- SRT Therapeutics has disclosed $47.4M raised across 1 round.
- Where is SRT Therapeutics headquartered?
- SRT Therapeutics is headquartered in San Diego, US.